JNJ
Price
$176.46
Change
-$0.94 (-0.53%)
Updated
Sep 16 closing price
Capitalization
424.98B
27 days until earnings call
NVS
Price
$122.78
Change
-$0.53 (-0.43%)
Updated
Sep 16 closing price
Capitalization
235.37B
41 days until earnings call
Interact to see
Advertisement

JNJ vs NVS

Header iconJNJ vs NVS Comparison
Open Charts JNJ vs NVSBanner chart's image
Johnson & Johnson
Price$176.46
Change-$0.94 (-0.53%)
Volume$7.96M
Capitalization424.98B
Novartis AG
Price$122.78
Change-$0.53 (-0.43%)
Volume$954.76K
Capitalization235.37B
JNJ vs NVS Comparison Chart in %
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. NVS commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Hold and NVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (JNJ: $176.46 vs. NVS: $122.78)
Brand notoriety: JNJ: Notable vs. NVS: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 95% vs. NVS: 62%
Market capitalization -- JNJ: $424.98B vs. NVS: $235.37B
JNJ [@Pharmaceuticals: Major] is valued at $424.98B. NVS’s [@Pharmaceuticals: Major] market capitalization is $235.37B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $685.53B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 4 FA rating(s) are green whileNVS’s FA Score has 3 green FA rating(s).

  • JNJ’s FA Score: 4 green, 1 red.
  • NVS’s FA Score: 3 green, 2 red.
According to our system of comparison, JNJ is a better buy in the long-term than NVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 2 TA indicator(s) are bullish while NVS’s TA Score has 6 bullish TA indicator(s).

  • JNJ’s TA Score: 2 bullish, 5 bearish.
  • NVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NVS is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -0.28% price change this week, while NVS (@Pharmaceuticals: Major) price change was -4.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.68%. For the same industry, the average monthly price growth was +1.00%, and the average quarterly price growth was +11.13%.

Reported Earning Dates

JNJ is expected to report earnings on Oct 14, 2025.

NVS is expected to report earnings on Oct 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.68% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($425B) has a higher market cap than NVS($235B). JNJ has higher P/E ratio than NVS: JNJ (18.89) vs NVS (17.90). NVS YTD gains are higher at: 30.717 vs. JNJ (24.958). JNJ has higher annual earnings (EBITDA): 35.6B vs. NVS (22.7B). JNJ has more cash in the bank: 18.9B vs. NVS (7B). NVS has less debt than JNJ: NVS (32.6B) vs JNJ (50.8B). JNJ has higher revenues than NVS: JNJ (90.6B) vs NVS (55.2B).
JNJNVSJNJ / NVS
Capitalization425B235B181%
EBITDA35.6B22.7B157%
Gain YTD24.95830.71781%
P/E Ratio18.8917.90106%
Revenue90.6B55.2B164%
Total Cash18.9B7B270%
Total Debt50.8B32.6B156%
FUNDAMENTALS RATINGS
JNJ vs NVS: Fundamental Ratings
JNJ
NVS
OUTLOOK RATING
1..100
6177
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
3116
SMR RATING
1..100
3229
PRICE GROWTH RATING
1..100
3253
P/E GROWTH RATING
1..100
7979
SEASONALITY SCORE
1..100
7565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVS's Valuation (14) in the Pharmaceuticals Major industry is in the same range as JNJ (15). This means that NVS’s stock grew similarly to JNJ’s over the last 12 months.

NVS's Profit vs Risk Rating (16) in the Pharmaceuticals Major industry is in the same range as JNJ (31). This means that NVS’s stock grew similarly to JNJ’s over the last 12 months.

NVS's SMR Rating (29) in the Pharmaceuticals Major industry is in the same range as JNJ (32). This means that NVS’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Price Growth Rating (32) in the Pharmaceuticals Major industry is in the same range as NVS (53). This means that JNJ’s stock grew similarly to NVS’s over the last 12 months.

JNJ's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as NVS (79). This means that JNJ’s stock grew similarly to NVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJNVS
RSI
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
48%
Momentum
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
46%
MACD
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
41%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
43%
Bullish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 15 days ago
42%
Bullish Trend 12 days ago
49%
Declines
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
45%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
57%
Aroon
ODDS (%)
Bullish Trend 1 day ago
33%
Bullish Trend 1 day ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVSE63.820.46
+0.72%
Avantis Responsible Emerging Mkts Eq ETF
QQH74.73-0.04
-0.05%
HCM Defender 100 Index ETF
LFEQ52.65-0.06
-0.12%
VanEck Lg/Flat Trend ETF
AVRE45.04-0.15
-0.33%
Avantis Real Estate ETF
USMV93.10-0.39
-0.42%
iShares MSCI USA Min Vol Factor ETF

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-0.53%
PFE - JNJ
59%
Loosely correlated
-0.29%
NVS - JNJ
54%
Loosely correlated
-0.43%
GSK - JNJ
50%
Loosely correlated
-0.62%
BIIB - JNJ
44%
Loosely correlated
+0.25%
BMY - JNJ
42%
Loosely correlated
-0.02%
More

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
-0.43%
GSK - NVS
67%
Closely correlated
-0.62%
AZN - NVS
61%
Loosely correlated
-0.63%
PFE - NVS
58%
Loosely correlated
-0.29%
JNJ - NVS
55%
Loosely correlated
-0.53%
SNY - NVS
50%
Loosely correlated
+0.51%
More